NOSU
NOTICE OF SUIT
12/11/2024
Back to search
Official data from USPTO
TITAN PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TITAN PHARMACY
ST13
US500000077207928Class
35, 44
Filing
77207928
Registration
3429834
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/11/2024
Trademark type
Word
Nice classes
35, 44
Filing date
06/16/2007
Registration date
05/20/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2017
Last transaction
04/07/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/08/2000
First use in commerce
12/08/2000
Drawing code
4
Owner type
03
Owner location
ASTORIA, NY
Examiner
MARTIN, JENNIFER
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Levron, Inc.
Representatives
LEVRON, INC.
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Retail pharmacy services; Mail order services featuring PRESCRIPTIONS AND PHARMACEUTICAL MEDICINE
Class 44
Pharmacists' services to make up prescriptions
Publications
History of USPTO decisions and trademark events.
27 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/15/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/15/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/15/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/28/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
06/21/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/21/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/20/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/29/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/29/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/29/2013
E815
TEAS SECTION 8 & 15 RECEIVED
06/17/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2008
PUBO
PUBLISHED FOR OPPOSITION
03/04/2008
NPUB
NOTICE OF PUBLICATION
02/13/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/29/2008
ALIE
ASSIGNED TO LIE
01/29/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/18/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/17/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/17/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/17/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/20/2007
GNRT
NON-FINAL ACTION E-MAILED
09/20/2007
CNRT
NON-FINAL ACTION WRITTEN
09/20/2007
DOCK
ASSIGNED TO EXAMINER
09/20/2007
NWAP
NEW APPLICATION ENTERED
06/21/2007
Continuous trademark protection
Get notified about every new filing that threatens TITAN PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.